SD 1 gmed-20220527x8k.htm FORM SD Form SD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM SD

 

 

SPECIALIZED DISCLOSURE REPORT



 

 

GLOBUS MEDICAL, INC.

(Exact name of registrant as specified in charter)

 

 

 



 

 

 

 

DELAWARE

 

001-35621

 

04-3744954

(State or other jurisdiction

of incorporation or organization)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)



2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA 19403

(Address of principal executive offices) (Zip Code)



KEITH PFEIL

Senior Vice President, Chief Financial Officer, Chief Accounting Officer

(610) 930-1800

(Name and telephone number, including area code, of the person to contact in connection with this report.)





Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

 



 

Rule 13p-1 under Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2021.

Rule 13q-1 under Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended _________.



 


 

Section 1 - Conflict Minerals Disclosure



Item 1.01 Conflict Minerals Disclosure and Report



Globus Medical, Inc. (the “Company”) is filing this Specialized Disclosure Report (“Form SD”), including the Conflict Minerals Report attached as Exhibit 1.01 hereto, for the calendar year ended December 31, 2021 to comply with Rule 13p-1 of the Securities Exchange Act of 1934, as amended. 



A copy of the Company’s Conflict Minerals Disclosure is publicly available at www.investors.globusmedical.com/investors-overview.



Item 1.02 Exhibit



The Company’s Conflict Minerals Report for calendar year 2021 is filed as Exhibit 1.01 to this Form SD and is incorporated herein by reference.



Section 2 Exhibits



Item 2.01 Exhibits



See the Exhibit Index below, which is incorporated by reference herein.



 

 

EXHIBIT INDEX

Exhibit No.

 

Description of Exhibit



 

 

1.01

 

Conflict Minerals Report of Globus Medical, Inc.




 

SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.





 

 



 

GLOBUS MEDICAL, INC.



 

(Registrant)



 

 

Dated:

May 27, 2022

/s/ KEITH PFEIL



 

Keith Pfeil



 

Senior Vice President



 

Chief Financial Officer



 

Chief Accounting Officer



 

(Principal Financial Officer)